- Business Wire•2 days ago
22nd Century Group, Inc. , a plant biotechnology company that is a leader in tobacco harm reduction, announced today that Crede CG III, Ltd. has dismissed claims against the Company in the on-going litigation related to a terminated China joint venture.
- Business Wire•21 days ago
22nd Century Group, Inc. , a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company prevailed again in the most recent phase of the lawsuit filed by Crede CG III, Ltd.
- Accesswire•23 days ago
LOS ANGELES, CA / ACCESSWIRE / February 1, 2017 / LD Micro is pleased to announce that the LD Micro Index is being reconstituted as of February 1, 2017. We believe that the existence of a true microcap ...
XXII : Summary for 22nd Century Group, Inc. Common - Yahoo Finance
22nd Century Group, Inc. (XXII)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.98 - 1.14|
|52 Week Range||0.71 - 1.71|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.65|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|